Bioservo Technologies AB Interim Report January – September 2021
Third quarter in figures · Net sales of SEK 2.3 M (1.8) · EBITDA of SEK -5.1 M (-4.8) · EBIT of SEK -6.3 M (-5.8) · Earnings for the period amounted to SEK -6.3 M (-5.8) · Earnings per share before and after dilution amounted to SEK -0.40 (-0.41) · Cash flow from operating activities for the period amounted to SEK -7.4 M (-1.0) First nine months in figures · Net sales of SEK 4.8 M (9.6) · EBITDA of SEK -22.5 M (-15.2) · EBIT of SEK -26.2 M (-18.2) · Earnings for the period was SEK -26.2 M (-18.2) · Earnings per share before and after dilution amounted